Open access · OA
via OpenAlex
Genetically enhanced mesenchymal stem cells for aging intervention
Jing-Hui LEI, Guang-Hui LIU, Si Wang
Shengming kexue · 2026
Abstract
Aging is an inevitable physiological process accompanied by a gradual decline in the function of adult stem cells, which is widely recognized as a core factor of various aging-related diseases, including cardiovascular diseases, diabetes, neurodegenerative diseases and osteoporosis. Mesenchymal stem cells (MSCs), due to their advantages such as multilineage differentiation potential, immunomodulatory capacity, and low immunogenicity, are considered the most promising cell transplantation materials for delaying aging and promoting regeneration. However, after transplantation, MSCs often face extremely low survival rates and short retention times in the harsh microenvironment of the aging body, which is characterized by oxidative stress, chronic inflammation, accumulation of toxic metabolites and reduced nutrient supply, severely limiting their therapeutic efficacy in clinical applications. To address this critical bottleneck, genetic enhancement strategies have emerged as a promising solution, which employ precise gene editing technologies such as CRISPR-Cas9 <?A3B2 pi129?>to modify target genes, thereby improving the homing ability of MSCs to damaged tissues, enhancing their resistance to adverse microenvironmental stress, and promoting their paracrine secretion of beneficial cytokines. These genetically enhanced MSCs show markedly superior therapeutic efficacy relative to wild-type MSCs in the treatment of aging and related diseases. Although the long-term safety and potential risks of genetically enhanced MSCs still require further evaluation through large-sample, long-term preclinical and clinical studies, they undoubtedly represent an important breakthrough direction for the development of next-generation safe and effective anti-aging therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3724/cbls.2026094
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
LEI, J., LIU, G., & Wang, S. (2026). Genetically enhanced mesenchymal stem cells for aging intervention. <em>Shengming kexue</em>. https://doi.org/10.3724/cbls.2026094
Vancouver
LEI J, LIU G, Wang S. Genetically enhanced mesenchymal stem cells for aging intervention. Shengming kexue. 2026. doi:10.3724/cbls.2026094.
BibTeX
@article{jinghui2026Geneti,
title = {Genetically enhanced mesenchymal stem cells for aging intervention},
author = {Jing-Hui LEI and Guang-Hui LIU and Si Wang},
journal = {Shengming kexue},
year = {2026},
doi = {10.3724/cbls.2026094},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oxidative Medicine and Cellular Longevity 2015
Open access · CC-BY
Cell Adhesion and Long-Term Survival of Transplanted Mesenchymal Stem Cells: A Prerequisite for Cell Therapy
Stem Cell Research 2008
Open access · OA
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
Astana Medical Journal 2026
Open access · OA
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
Bone 2014
Citation only
Characterization of bone marrow-derived mesenchymal stem cells in aging
Frontiers in Medicine 2018
Open access · CC-BY
Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
Stem Cells Translational Medicine 2022
Open access · CC-BY